These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 8552747)
1. Strategies of research for a vaccine against AIDS. Essex M Hist Philos Life Sci; 1995; 17(1):141-9. PubMed ID: 8552747 [TBL] [Abstract][Full Text] [Related]
2. [AIDS vaccines: an enigma in vaccine development]. Dorner F; Barrett N Wien Klin Wochenschr; 1990 Jan; 102(2):51-8. PubMed ID: 1689919 [TBL] [Abstract][Full Text] [Related]
3. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma. Gómez CE; Abaitua F; Rodríguez D; Esteban M Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077 [TBL] [Abstract][Full Text] [Related]
4. The hunt for the AIDS vaccine. Essex M AIDS Asia; 1995; 2(3):10-3. PubMed ID: 12319586 [TBL] [Abstract][Full Text] [Related]
5. Lessons from the cat: development of vaccines against lentiviruses. Dunham SP Vet Immunol Immunopathol; 2006 Jul; 112(1-2):67-77. PubMed ID: 16678276 [TBL] [Abstract][Full Text] [Related]
6. The prospects for and pathways toward a vaccine for AIDS. Francis DP; Petricciani JC N Engl J Med; 1985 Dec; 313(25):1586-90. PubMed ID: 2999596 [TBL] [Abstract][Full Text] [Related]
7. The development of an AIDS vaccine: progress and promise. Fauci AS; Fischinger PJ Public Health Rep; 1988; 103(3):230-6. PubMed ID: 3131812 [TBL] [Abstract][Full Text] [Related]
8. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P). Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of immune responses induced by HIV-1 gp120 in rhesus macaques: effect of vaccination on challenge with pathogenic strains of homologous and heterologous simian human immunodeficiency viruses. Kumar A; Lifson JD; Silverstein PS; Jia F; Sheffer D; Li Z; Narayan O Virology; 2000 Aug; 274(1):149-64. PubMed ID: 10936096 [TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine. McFarland EJ; Borkowsky W; Fenton T; Wara D; McNamara J; Samson P; Kang M; Mofenson L; Cunningham C; Duliege AM; Sinangil F; Spector SA; Jimenez E; Bryson Y; Burchett S; Frenkel LM; Yogev R; Gigliotti F; Luzuriaga K; Livingston RA; J Infect Dis; 2001 Nov; 184(10):1331-5. PubMed ID: 11679925 [TBL] [Abstract][Full Text] [Related]
11. Update on HIV vaccines. Meldorf M; Corey L STEP Perspect; 1997; 9(2):5-6, 8-9. PubMed ID: 11364929 [TBL] [Abstract][Full Text] [Related]
12. A fresh injection of interest for vaccines. AIDS Anal Afr; 1998 Feb; 8(1):3, 6. PubMed ID: 12293289 [TBL] [Abstract][Full Text] [Related]
13. Current status of the development of an AIDS vaccine. Lasky LA Crit Rev Immunol; 1989; 9(3):153-72. PubMed ID: 2673294 [TBL] [Abstract][Full Text] [Related]
14. Helminth infection suppresses T-cell immune response to HIV-DNA-based vaccine in mice. Da'Dara AA; Lautsch N; Dudek T; Novitsky V; Lee TH; Essex M; Harn DA Vaccine; 2006 Jun; 24(24):5211-9. PubMed ID: 16675073 [TBL] [Abstract][Full Text] [Related]
15. Avoiding deceptive imprinting of the immune response to HIV-1 infection in vaccine development. Muller S Int Rev Immunol; 2004; 23(5-6):423-36. PubMed ID: 15370274 [TBL] [Abstract][Full Text] [Related]
16. Let's go for human testing of vaccine, says UNAIDS. UN Chron; 1999; 36(1):23. PubMed ID: 12295240 [TBL] [Abstract][Full Text] [Related]
17. Gag-specific immune enhancement of lentiviral infection after vaccination with an adenoviral vector in an animal model of AIDS. Klonjkowski B; Klein D; Galea S; Gavard F; Monteil M; Duarte L; Fournier A; Sayon S; Górna K; Ertl R; Cordonnier N; Sonigo P; Eloit M; Richardson J Vaccine; 2009 Feb; 27(6):928-39. PubMed ID: 19070641 [TBL] [Abstract][Full Text] [Related]
18. Lymphoproliferative responses to recombinant HIV-1 envelope antigens in neonates and infants receiving gp120 vaccines. AIDS Clinical Trial Group 230 Collaborators. Borkowsky W; Wara D; Fenton T; McNamara J; Kang M; Mofenson L; McFarland E; Cunningham C; Duliege AM; Francis D; Bryson Y; Burchett S; Spector SA; Frenkel LM; Starr S; Van Dyke R; Jimenez E J Infect Dis; 2000 Mar; 181(3):890-6. PubMed ID: 10720509 [TBL] [Abstract][Full Text] [Related]
19. Prime-boost strategies in DNA vaccines. Dale CJ; Thomson S; De Rose R; Ranasinghe C; Medveczky CJ; Pamungkas J; Boyle DB; Ramshaw IA; Kent SJ Methods Mol Med; 2006; 127():171-97. PubMed ID: 16988455 [TBL] [Abstract][Full Text] [Related]